メインナビゲーションにスキップ 検索にスキップ メインコンテンツにスキップ

Therapeutic drug monitoring of etoposide in a 14-day infusion for non-small-cell lung cancer

  • Yuichi Ando
  • , Hironobu Minami
  • , Hideo Saka
  • , Masahiko Ando
  • , Shuzo Sakai
  • , Kaoru Shimokata

研究成果: ジャーナルへの寄稿 › 学術論文 › 査読

6   !!Link opens in a new tab 被引用数 (Scopus)

抄録

We investigated whether a constant plasma concentration could be obtained by the individualized administration of low-dose, prolonged-infusional etoposide. Etoposide was infused for 14 days at 40 mg/m2/day initially in patients with inoperable non-small-cell lung cancer. The infusion rate was modified based upon the etoposide concentration at 24 h following the initiation of the infusion (C24) to achieve a target concentration of 1.5 μg/ml. We postulated that severe toxicities could be avoided by maintaining the steady-state concentration at less than 2 μg/ml, while antitumor activity could be expected if the steady-state concentration was maintained at more than 1 μg/ml. In a total of 21 courses in 12 patients, the mean etoposide dose was 35 ± 6 mg/m2 daily. The C24 was 1.8 ± 0.4 μg/ml and ranged from 1.1 to 2.9 μg/ml. Following dose modification, the mean concentration from 96 to 336 h (C(mean)) was 1.6 ± 0.2 μg/ml and ranged from 1.2 to 2.0 μg/ml. The toxicities were well-tolerated except for one patient with WHO grade 4 leukopenia and neutropenia who developed infectious complications. There were no treatment-related deaths. Following dose modification, the inter-patient variability was decreased successfully. Although this pharmacologically-guided method needs to be validated using more patients, it could be used for therapeutic drug monitoring.

本文言語英語
ページ(範囲)200-205
ページ数6
ジャーナルJapanese Journal of Cancer Research
巻87
号2
DOI
出版ステータス出版済み - 02-1996
外部発表はい

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

  1. SDG 3 - すべての人に健康と福祉を
    SDG 3 すべての人に健康と福祉を

All Science Journal Classification (ASJC) codes

  • 腫瘍学
  • 癌研究

フィンガープリント

「Therapeutic drug monitoring of etoposide in a 14-day infusion for non-small-cell lung cancer」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル